Colgate-PalmoliveCL
About Colgate-Palmolive
Colgate-Palmolive is a global consumer products company built around two core pillars: oral, personal, and home care under the Colgate umbrella, and pet nutrition under the Hill's brand. The oral care franchise — anchored by Colgate toothpaste, manual and powered toothbrushes, and mouthwash — is the single largest contributor to sales and holds a leading global share of the toothpaste category. Personal care spans bar and liquid soaps (Palmolive, Softsoap, Irish Spring), deodorants (Speed Stick, Lady Speed Stick), and shampoos, while home care covers dish and surface cleaners. Hill's Pet Nutrition, sold through veterinarians and specialty retailers under the Science Diet and Prescription Diet labels, has grown into a disproportionately profitable pillar alongside oral care.
Serious holders track a familiar set of structural questions: foreign-exchange translation, since a majority of revenue is earned outside the United States and often in emerging markets; input-cost cycles in agricultural commodities, packaging resins, and energy that flow through gross margin; and retailer concentration, with mass merchants, club stores, and e-commerce platforms wielding pricing leverage. Regulatory exposure spans product safety, ingredient disclosure, and advertising claims across dozens of jurisdictions. Capital allocation has long favored dividends and share repurchases funded by consistent free cash flow, with bolt-on acquisitions rather than transformative deals. Governance features a unitary board and a management team typically promoted from within the operating ranks.
The company traces its origins to a starch, soap, and candle business founded by William Colgate in New York in 1806, and to the Palmolive-Peet soap enterprise that grew out of B.J. Johnson Soap Company in Milwaukee. The two merged in 1928 to form Colgate-Palmolive-Peet, later shortened to Colgate-Palmolive Company. Successive decades brought international expansion, the 1976 acquisition of Hill's Pet Products, and a long series of divestitures that narrowed the portfolio away from unrelated businesses such as Kendall healthcare and various food and household lines. Today the company operates as a single publicly traded entity headquartered in New York, organized around geographic consumer divisions plus the standalone Hill's segment.
Revenue comes from selling branded packaged goods through mass merchandisers, grocery chains, drugstores, wholesalers, distributors, and increasingly direct and third-party e-commerce channels, with Hill's additionally moving through veterinary clinics and pet specialty retailers. Sales are transactional rather than contracted, so pricing power depends on brand equity, shelf presence, marketing intensity, and dentist and veterinarian endorsement rather than on long-term supply agreements. Competitive position rests on the toothpaste franchise's global scale against Procter & Gamble's Crest, on personal and home care rivalry with Unilever, Henkel, and Reckitt, and on Hill's contest with Mars-owned Royal Canin and Nestlé Purina. Emerging markets — Latin America, Asia, and Africa-Eurasia — account for a substantial share of sales and a meaningful part of the growth story.
Company profile by LineVest editorial. Journalism, not investment advice. Commission a full SEC-based report on Colgate-Palmolive →
Colgate-Palmolive coverage
No Colgate-Palmolive stories yet — LineVest publishes U.S. market news daily, and new coverage of Colgate-Palmolive will appear here automatically.
Browse the latest U.S. market news →Go deeper than the headline
You just read what happened. Here's how to read what it means.
The U.S. market, every morning — free
LineVest Daily lands in your inbox before every opening bell: the key U.S. markets stories, earnings, disclosures and foreign flows — in plain English. Free, no card required.
Full report on Colgate-Palmolive
We read Colgate-Palmolive's latest SEC filing in full — financials under US GAAP, governance, and what it means for the stock. PDF in your inbox within 3 hours.
$12 · one-time
Get the Colgate-Palmolive reportFollow the whole market
Reading several U.S. stocks a week? Read every analysis article the moment it publishes — full daily U.S. market coverage plus the 90-day archive.
$9.99 · monthly
SubscribeIndependent journalism based on primary SEC filings — not investment advice. No brokerage affiliation.